Nurix Therapeutics (NasdaqGM:NRIX) FY Conference Transcript

Nurix Therapeutics (NasdaqGM:NRIX) FY Conference September 08, 2025 01:30 PM ET Speaker0Hi. Welcome to our our fireside chat with NeurIX. I am Rob Perns, managing director and senior biotech analyst at HC Wainwright, and I'm joined by Arthur Sands, the CEO of NeurIX. Arthur, thank you joining us today.Speaker1Rob, thank you for having us.Speaker0No problem. So I understand you have some slides first, so why don't you start off there?Speaker1I do. I'll start out with a few slides just to frame things. We hav ...